Search

everythinglearnresearchcommunity

for

Search:↓

Green tea component EGCG may help prevent hair loss by changing microRNA levels in certain scalp cells.

Androgens can cause hair growth in some areas but hair loss on the scalp.

Silymarin improves hair follicle health better than vitamin C by boosting cell growth and reducing oxidative stress.

Cannabinoids may help some skin conditions but more research is needed.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Cyproterone acetate is effective for treating hirsutism, but some patients may feel worse on low-dose maintenance therapy.

Finasteride's effect on hair loss and prostate enlargement depends on its binding to an enzyme, with maximum impact at 0.2 mg dose.

Clascoterone is safe for the heart, even at high doses.

CG2001 is safe and well-tolerated for treating hair loss, with fewer side effects than oral finasteride.

A new surgical method using special sutures significantly reduced wound size and prevented disease return in patients with a scarring scalp condition.

Testosterone's role in women's sex drive is unclear and needs more research, as low levels don't always mean less sexual interest and high levels can cause side effects.

Methotrexate for rheumatoid arthritis often causes side effects like diarrhea, fatigue, and hair loss, especially at higher doses.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Psychological factors like depression may be more important than zinc, folate, and vitamin B12 levels in causing scalp pain in people with hair loss.

Higher cell number PRP improves hair density and diameter more than lower cell number PRP.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Most patients stop using topical minoxidil due to side effects.

Low-dose minoxidil effectively enhances facial hair with minimal side effects.

Finasteride increases hair count in men with hair loss, but the effect isn't permanent and hair loss returns if treatment stops.

Partial hair-sparing brain radiotherapy is possible and doesn't affect cancer control but still causes noticeable hair loss.

The herbal mix (Biochanin A, Acetyl tetrapeptide-3, and Ginseng Extracts) and the 3% Minoxidil solution are equally effective in treating hair loss, but the herbal mix has fewer side effects.

Topical spironolactone and minoxidil both effectively treat female hair loss, but spironolactone has fewer side effects.

Oral spironolactone may be effective for female pattern hair loss with a low rate of side effects.

Spermidine may help reduce hair loss and deserves further testing as a treatment.

Curly hair in certain scalp areas can be an early sign of hair loss.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Stopping zolpidem improved hair loss caused by self-inflicted scalp injuries during sleep.

Men with more severe hair loss had a lower risk of schizophrenia, but hair loss and testosterone levels were not linked.